DUBLIN, July 19, 2016 /PRNewswire/ --
Research and Markets has announced the addition of the "Point-of-Care Diagnostics Market - Global Forecast to 2021" report to their offering.
The growth of the overall point-of-care diagnostics market is driven by factors such as prevalence of lifestyle and infectious diseases and the increasing inclination towards home healthcare across the globe. In addition, healthcare decentralization, miniaturization of POC testing devices, increasing number of conferences and events, and POC tests with multiplexing capabilities are offering new growth opportunities for players in the point-of-care diagnostics market.
On the other hand, stringent and time-consuming regulatory policies and pricing pressure owing to reimbursement cuts and budget constraints are the key challenges faced by the market players involved in the POC diagnostics market.
Geographically, North America (comprising the U.S. and Canada) is expected to command the largest share of the point-of-care diagnostics market in 2016, followed by Europe. A number of factors such as growing prevalence of lifestyle diseases, increasing number of product approvals, and rising government initiatives are contributing to the growth of the North American point-of-care diagnostics market. However, rising pricing pressure and slow approval of multi-analyte POC products is limiting the growth of point-of-care diagnostics market in North America.
The point-of-care diagnostics market consists of a large number of big, medium, and small-sized companies. As of 2015, the point-of-care diagnostics market was dominated by Roche Diagnostics Limited (Switzerland), Johnson & Johnson (U.S.), and Alere, Inc. (U.S.).
- Abbott Laboratories, Inc.
- Alere Inc.
- Beckman Coulter, Inc.
- Becton, Dickinson and Company
- Instrumentation Laboratory
- Johnson & Johnson
- Nova Biomedical
- PTs Diagnostics
- Roche Diagnostics Limited
- Siemens AG
Key Topics Covered:
2 Research Methodology
3 Executive Summary
4 Premium Insights
5 Market Overview
6 Industry Trends
7 Point-Of-Care Diagnostics Market, By Product
8 Point-Of-Care Diagnostics Market, By Prescription Mode
9 Point-Of-Care Diagnostics Market, By End User
10 Point-Of-Care Diagnostics Market, By Region
11 Competitive Landscape
12 Company Profiles
For more information visit http://www.researchandmarkets.com/research/plfdx6/pointofcare
Research and Markets
Laura Wood, Senior Manager
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/point-of-care-diagnostics-market-worth-usd-3696-billion-by-2021---increasing-inclination-towards-home-healthcare---research-and-markets-300300679.html
SOURCE Research and Markets